82: GLP-1s Beyond Weight Loss – The Future of Women’s Health, Fertility, Hormones, and Longevity | SXSW Panel Discussion Featuring McCall McPherson, Natalie Crawford, Jessica Shepherd & Shannon Ritchey
Podcast: Modern Thyroid and WellnessPublished On: Thu May 21 2026
Description: What if GLP-1 medications are not just changing weight loss—but completely transforming the future of women’s health?In this special SXSW panel discussion, Shannon Ritchey moderates an eye-opening conversation with leading experts McCall McPherson, Natalie Crawford, and Jessica Shepherd about the rapidly evolving role of GLP-1 medications in fertility, thyroid health, inflammation, menopause, longevity, metabolic health, and chronic disease prevention.This conversation goes far beyond weight loss. The panel explores how GLP-1 medications may reduce systemic inflammation, improve insulin resistance, support fertility outcomes, influence hormone health during perimenopause and menopause, protect cardiovascular health, and potentially reshape the future of longevity medicine.The discussion also tackles common myths, cancer fears, muscle loss concerns, microdosing strategies, fertility safety, lifestyle foundations, and the importance of preserving muscle while using these medications.🔑 Key Topics CoveredWhy GLP-1 medications are far more than “weight loss drugs”How GLP-1s improve insulin sensitivity and metabolic functionThe powerful role GLP-1s may play in reducing systemic inflammationWhy microdosing GLP-1s is becoming an emerging strategy in medicineThe truth about thyroid cancer concerns and current research findingsHow under-fueling and poor nutrition contribute to muscle loss on GLP-1sWhy strength training and protein intake are essential while using GLP-1sThe connection between inflammation, thyroid disease, and metabolic dysfunctionHow GLP-1s may support fertility in women with PCOS and insulin resistanceWhy GLP-1s should be stopped before pregnancy attemptsThe impact of chronic inflammation on ovarian reserve and fertility outcomesHow GLP-1s may improve endometriosis symptoms and inflammatory reproductive conditionsThe role of GLP-1s in perimenopause, menopause, and hormonal agingWhy estrogen decline impacts glucose regulation and inflammationThe connection between visceral fat, inflammation, and chronic diseaseEmerging research on GLP-1s, addiction behavior, fatty liver disease, and longevityWhy personalized medicine and lifestyle intervention remain essential🧠 GLP-1s Are Not Just About Eating LessOne of the strongest themes throughout the panel:👉 GLP-1 medications are not simply making people lose weight because they eat less.According to McCall McPherson, these medications fundamentally improve:Metabolic functionInsulin sensitivityInflammatory pathwaysPhysiological responses to foodThis is especially important for women with:Thyroid dysfunctionPCOSAutoimmune diseaseMenopause-related metabolic changesThe panel repeatedly emphasizes:👉 Weight gain is often not a willpower problem—it is a metabolic and inflammatory problem. ⚡ The Emerging Power of MicrodosingA major topic discussed is microdosing GLP-1s.What Is Microdosing?Using:Much smaller dosesMore personalized dosing strategiesFlexible adjustments based on symptoms and goalsRather than aggressively increasing medication doses, microdosing may help:Reduce nauseaImprove tolerabilityAllow proper fueling and protein intakePreserve muscle massMaintain metabolic benefitsMcCall McPherson explains that many patients experience:Significant inflammation reductionMetabolic improvementBetter energy…even at very low doses.🔥 Inflammation: The Hidden Driver of DiseaseThroughout the panel, inflammation is described as one of the biggest underlying drivers of:Fertility strugglesThyroid diseaseInsulin resistanceCardiovascular diseaseJoint painMenopausal symptomsThe panelists repeatedly explain that GLP-1s appear to dramatically reduce inflammation—sometimes within days.Why This MattersReducing inflammation may influence:Hormonal signalingOvarian functionMetabolic flexibilityLongevity outcomesThis is one reason the panel believes GLP-1s may eventually become indicated for many conditions beyond obesity and diabetes.🦋 Thyroid Disease, Autoimmunity & GLP-1sMcCall McPherson shares extensive clinical observations from treating thyroid patients with GLP-1s.Key Insights DiscussedSignificant reductions in inflammatory markersImprovements in Hashimoto’s antibody levelsBetter metabolic flexibility in thyroid patientsPotential reduction in future autoimmune riskThe panel also directly addresses concerns about thyroid cancer.What Current Research ShowsThe fear largely originated from rodent studies involving:Extremely high dosesRat thyroid tissue with dense GLP receptorsCurrent human data has not shown meaningful increased thyroid cancer risk.In fact: 👉 Some studies suggest reductions in several cancer risks while using GLP-1s.💪 Muscle Loss, Protein & Strength TrainingOne of the biggest concerns surrounding GLP-1s is muscle loss.The panel makes an important distinction:👉 Muscle loss is not inherently caused by the medication itself 👉 It is often caused by under-fueling and inadequate resistance trainingThe Real ProblemSome individuals:Eat far too littleAvoid proteinStop strength trainingLose weight too quicklyThis creates:SarcopeniaReduced metabolic healthPoor long-term outcomesThe SolutionAccording to Shannon Ritchey:Lift heavyTrain close to muscular failurePrioritize protein intakePreserve and build muscle while losing fatThe panel strongly reinforces:👉 Muscle is metabolic currency for women’s long-term health. 👶 Fertility, PCOS & PregnancyNatalie Crawford discusses the growing role of GLP-1s in fertility medicine.Conditions Showing PromisePCOSInsulin resistanceChronic inflammationEndometriosisRecurrent pregnancy lossWhy It MattersInsulin resistance impacts:OvulationHormone productionEgg qualityFertility treatment outcomesReducing inflammation and improving metabolic health may dramatically improve reproductive outcomes.Important Safety NoteGLP-1s are not currently recommended during pregnancy.Patients are advised to: 👉 Stop GLP-1 medications at least two months before attempting conception. 🌸 Perimenopause, Menopause & Hormonal AgingJessica Shepherd explains how declining estrogen impacts:Glucose regulationInflammationVisceral fatCardiovascular riskMetabolic functionThe panel highlights that menopause is: 👉 A whole-body hormonal transition—not just a reproductive event.Why GLP-1s May Matter in MidlifeAs estrogen declines:Insulin resistance often worsensVisceral fat increasesInflammation risesGLP-1s may help:Improve metabolic functionReduce inflammatory burdenSupport healthier aging outcomes ❤️ Cardiovascular Health & LongevityAnother major theme:👉 Cardiovascular disease remains the number one killer of women.The panel discusses research showing GLP-1s may:Reduce cardiovascular eventsImprove inflammatory markersLower mortality riskPotential Longevity ImplicationsImproved:Insulin sensitivityMetabolic functionInflammatory regulation…may contribute to:Longer health spanBetter aging outcomesReduced chronic disease risk 🍷 Addiction, Fatty Liver & Emerging ResearchThe discussion also touches on newer research areas.Emerging Benefits Being StudiedReduced alcohol cravingsImproved addictive behaviorsBetter fatty liver disease outcomesImproved sperm qualityPotential ovarian longevity benefitsThe panel emphasizes: 👉 Research is still evolving, but the possibilities are significant.🌱 Lifestyle Still Matters MostDespite enthusiasm around GLP-1s, every panelist strongly reinforces:👉 Medication is not a replacement for lifestyle.Foundational habits remain critical:Resistance trainingProtein intakeSleepStress managementNutritionNervous system regulationThe medications work best when paired with: 👉 Sustainable lifestyle change. 🌟 Final TakeawayThis SXSW discussion makes one thing very...
The note was deleted
The note was saved
Your message was sent